Niemann, Carsten U.
Copenhagen University Hospital · Rigshospitalet
3 papers on CoChatORCID 0000-0001-9880-5242
Most cited papers
- Verified
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
Ahn, I. E., Farooqui, M. Z. H., Tian, X., Valdez, J., Sun, C., Soto, S., Lotter, J., Housel, S., Stetler-Stevenson, M., Yuan, C. M., et al. (2018) · Blood
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 205
- Verified
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
de Weerdt, I., Hofland, T., de Boer, R., Dobber, J. A., Dubois, J., van Nieuwenhuize, D., Mobasher, M., de Boer, F., Hoogendoorn, M., Velders, G. A., et al. (2019) · Blood Advances
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 110
- Verified
Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial
Jerkeman, M., Hutchings, M., Räty, R., Wader, K. F., Laurell, A., Kuitunen, H., Toldbod, H., Pedersen, L. B., Eskelund, C. W., Grønbæk, K., et al. (2016) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free